Our mission is to help you obtain financial freedom. Checkout Our Youtube Channel Checkout Our Youtube Channel
Blog

$NVAX Receives FDA Approval, Key Price Targets After 10%+ Intraday Rally

Novavax (NVAX) has been one of our best performing stocks that has been trading in an accumulation range between $7 and $9. I believe that NVAX is trending for an upward breakout in Q4. The FDA has approved NVAX’s COVID vaccine for patient ages 12+, and the European Union is set to make a decision in October. I believe that NVAX has promising short-term outlook that will lead to a rally with a break above $9. So far $9.18 has been a key resistance target, but I believe that NVAX will ultimately break out to the light blue resistance level at $16.21

TradingView chart:
https://www.tradingview.com/chart/NVAX/sG5ojvU3-NVAX-Key-Price-Targets-After-10-Intraday-Rally/

0 Comments
Inline Feedbacks
View all comments

More ClearValue Insights

Best Interest Rates for November 2024 Revealed: Savings, Checking, CDs, and Brokerage Accounts

Here are the best interest rates for November 2024: Savings Account Interest Rates Big Banks Regional Banks Online Banks Summary: Online banks offer the best savings rates, with SoFi at 4.20% and Marcus at 4.10%. Big and regional banks fall short, offering as low as 0.01%, except for Arvest Bank at 0.25%. Checking Account Interest […]

Read More
Default Thumbnail

Matching 401k Contributions to an HSA

In this video at the :45 mark, Brian stated that in 2025 employers would be able to make matching 401k contributions to an HSA rather than to a Pre-Tax Retirement account. Can anyone in the community point me to documentation (preferably on irs.gov) that clearly states this allowance? I would like to forward the information […]

Read More
Default Thumbnail

TLT

Anyone investing in the ETF

Read More